KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income - MinorityNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Quest Diagnostics (DGX) Net Income towards Common Stockholders (2016 - 2025)

Historic Net Income towards Common Stockholders for Quest Diagnostics (DGX) over the last 17 years, with Q3 2025 value amounting to $214.0 million.

  • Quest Diagnostics' Net Income towards Common Stockholders rose 753.77% to $214.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $844.0 million, marking a year-over-year increase of 1641.38%. This contributed to the annual value of $867.0 million for FY2024, which is 236.13% up from last year.
  • Quest Diagnostics' Net Income towards Common Stockholders amounted to $214.0 million in Q3 2025, which was up 753.77% from $250.0 million recorded in Q2 2025.
  • In the past 5 years, Quest Diagnostics' Net Income towards Common Stockholders registered a high of $599.0 million during Q2 2021, and its lowest value of $76.0 million during Q4 2022.
  • Its 5-year average for Net Income towards Common Stockholders is $252.5 million, with a median of $204.0 million in 2023.
  • As far as peak fluctuations go, Quest Diagnostics' Net Income towards Common Stockholders skyrocketed by 129800.0% in 2021, and later tumbled by 7822.35% in 2022.
  • Quest Diagnostics' Net Income towards Common Stockholders (Quarter) stood at $349.0 million in 2021, then crashed by 78.22% to $76.0 million in 2022, then skyrocketed by 113.16% to $162.0 million in 2023, then increased by 20.99% to $196.0 million in 2024, then rose by 9.18% to $214.0 million in 2025.
  • Its Net Income towards Common Stockholders stands at $214.0 million for Q3 2025, versus $250.0 million for Q2 2025 and $184.0 million for Q1 2025.